An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Mayo Clinic Hospital in Arizona, Phoenix, Arizona

Mayo Clinic in Rochester, Rochester, Minnesota

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah

University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin